The event began with the intervention of the president of AMUMA, Sonia Marchán, and the authorities present at the event. “There were many candidates for the awards, because fortunately there are many people who get involved with AMUMA every day”, Marchán commented. Likewise, the president of the association explained that “AMUMA was born in 1997 as a group made up of women affected by breast cancer, which has been growing and changing, expanding services and adapting to the needs that are being identified within the group”.
The mayor of Ciudad Real, Eva María Masías, who has been supported by a large representation of the Municipal Corporation, has been very excited about this distinction, alleging that “it is a very important day both professionally and personally”, thanking you for having thought of her for this distinction. “I think there are many brave women who are fighting and who deserve this award as well. For this reason, I will always carry this distinction with great pride, especially honoring all the associates, all those who fight against this terrible disease”, Masías stated, adding that “from the first minute he became mayor, he assumed a strong commitment to the association” and, in fact, in the last year since the City Council has inaugurated the “Jardín de Amuma”, a floral space created in the Gasset Park in commemoration and memory of Teresa Espinosa and all the people who died as a result of the breast cancer; The “pink bench” was also launched in the area of the Ciudad Real University Hospital, representing all the people who have suffered or are suffering from breast and/or gynecological cancer as support and accompaniment along the way.
During the delivery of the distinction, the mayor recalled, deeply moved, Teresa Espinosa, who died of this terrible disease and who worked tirelessly for AMUMA for years. “Thank you for having made history, but not to achieve your own successes, but history so that all sick women and so that the future of many of us is easier”, Masías congratulated.
Carmen Teresa Olmedo, Delegate of the Board in Ciudad Real, has thanked AMUMA for the work it has carried out on a daily basis and for 25 years. “Her work has meant a very important advance in treatments for this type of cancer,” said Olmedo, who also thanked all those affected, families and health workers who are fighting the disease for their personalized attention. “They have been a very important pillar in this prevention work,” added the Delegate, who also highlighted the genomic test that has been applied for several years and that allows discerning which treatments are best in each case. Personally, Olmedo added that “as a woman from Castile-La Mancha, I feel very proud of the association and the work they do with all women.”
From the Provincial Council, Petra Sánchez has encouraged the association to continue working in this line, alleging that “in the Provincial Council they will always find a strong ally because they understand that these associations need the support of the Administrations”.
The distinction of ‘Exemplary Member’ has fallen to the figure of Marisa Ortega Martín, who has been very happy and nervous about this enormous distinction. “We will continue with AMUMA working with all women in everything that is necessary,” she said.
From the Don Gil Archers Club, they have declared that they are very proud of this distinction. “We just wanted to contribute to the enjoyment of all these women and, if possible, to their improvement”, referring to the various workshops that they have selflessly organized in conjunction with AMUMA for women affected by breast cancer, since the practice of This sport is beneficial for one of the main sequelae of the disease, such as lymphedema, since it allows the contraction and relaxation of the muscle groups involved during its practice and favors lymphatic circulation, being beneficial both as a prevention and as a of treatment for the affected arms.
After the awarding of distinctions and recognitions, AMUMA has donated a check worth 10,000 euros to the GEICAM Foundation, contributing to the financing of the Pearl study, focused on determining the best treatment sequence for metastatic breast cancer with positive hormone receptors .